Neurosarcoidosis: Clinical experience and diagnostic pitfalls

European Neurology

Volumn 51, Issue 2, 2004, Pages 84-88

  Kellinghaus, C ^a   Schilling, M ^a   Ludemann P ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Central nervous system; Diagnostic criteria; Neurosarcoidosis; Sarcoidosis

Indexed keywords

IMMUNOGLOBULIN G; PREDNISOLONE;

ADULT; ANAMNESIS; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CRANIAL NEUROPATHY; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMMUNOGLOBULIN PRODUCTION; LABORATORY TEST; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; PATIENT; PLEOCYTOSIS; PRIORITY JOURNAL; PROBABILITY; REMISSION; SARCOIDOSIS; SYMPTOM; THORAX RADIOGRAPHY;

CRANIAL NERVE DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; GALLIUM RADIOISOTOPES; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; MALE; NERVOUS SYSTEM DISEASES; PEPTIDYL-DIPEPTIDASE A; RADIOGRAPHY; SARCOIDOSIS; THORAX;

EID: 1542405289     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076534     Document Type: Article

References (26)

1. American Thoracic Society (ATS): Statement on sarcoidosis, adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-755.
2. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J: Sarcoidosis and its neurological manifestations. Arch Neurol 1985;42:909-917.
3. Delaney P: Neurologic manifestations in sarcoidosis: Review of the literature, with a report of 23 cases. Ann Intern Med 1977;87:336-345.
4. Scott TF: Neurosarcoidosis: Progress and clinical aspects. Neurology 1993;43:8-12.
5. Cipri S, Gambardella G, Campolo C, Mannino R, Consoli D: Unusual clinical presentation of cerebral-isolated sarcoidosis. Case report and review of the literature. J Neurosurg Sci 2000; 44:140-144.
6. Uchino M, Nagao T, Harada N, Shibata I, Hamatani S, Mutou H: Neurosarcoidosis without systemic sarcoidosis - case report. Neurol Med Chir (Tokyo) 2001;41:48-51.
7. Chapelon C, Ziza JM, Piette JC, Levy Y, Raguin G, Wechsler B, Bitker MO, Bletry O, Laplane D, Bousser MG: Neurosarcoidosis: Signs, course and treatment in 35 confirmed cases. Medicine (Baltimore) 1990;69:261-276.
8. Oksanen V: Neurosarcoidosis: Clinical presentations and course in 50 patients. Acta Neurol Scand 1986;73:283-290.
9. Salazar A, Mana J, Albareda JM, Badrinas F, Fernandez-Nogues F: Neurosarcoidosis: presentation of 14 cases. Med Clin (Barc) 1993;100:292-295.
10. Sharma OP: Neurosarcoidosis: A personal perspective based on the study of 37 patients. Chest 1997;112:220-228.
11. Nowak DA, Widenka DC: Neurosarcoidosis: A review of its intracranial manifestation. J Neurol 2001;248:363-372.
12. Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, Scadding JW, Thompson EJ, Chamoun V, Miller DH, McDonald WI, Mitchell D: Central nervous system sarcoidosis - diagnosis and management. QJM 1999;92:103-117.
13. Galassi G, Gibertoni M, Mancini A, Nemni R, Volpi G, Merelli E, Vacca G: Sarcoidosis of the peripheral nerve: Clinical, electrophysiological and histological study of two cases. Eur Neurol 1984;23:459-465.
14. Nemni R, Galassi G, Cohen M, Hays AP, Gould R, Singh N, Bressman S, Gamboa ET: Symmetric sarcoid polyneuropathy: Analysis of a sural nerve biopsy. Neurology 1981;31:1217-1223.
15. Borucki SJ, Nguyen BV, Ladoulis CT, McKendall RR: Cerebrospinal fluid immunoglobulin abnormalities in neurosarcoidosis. Arch Neurol 1989;46:270-273.
16. Dale JC, O'Brien JF: Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis. Mayo Clin Proc 1999;74:535.
17. Tahmoush AJ, Amir MS, Connor WW, Farry JK, Didato S, Ulhoa-Cintra A, Vasas JM, Schwartzman RJ, Israel HL, Patrick H: CSF-ACE activity in probable CNS neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:191-197.
18. Schweisfurth H, Schioberg-Schiegnitz S, Kuhn W, Parusel B: Angiotensin I converting enzyme in cerebrospinal fluid of patients with neurological diseases. Klin Wochenschr 1987;65:955-958.
19. Oksanen V, Fyhrquist F, Somer H, Gronhagen-Riska C: Angiotensin converting enzyme in cerebrospinal fluid: A new assay. Neurology 1985;35:1220-1223.
20. Jones DB, Mitchell D, Horn DB, Edwards CR: Cerebrospinal fluid angiotensin converting enzyme levels in the diagnosis of neurosarcoidosis. Scott Med J 1991;36:144-145.
21. Zajicek JP: Neurosarcoidosis. Curr Opin Neurol 2000;13:323-325.
22. Mana J: Magnetic resonance imaging and nuclear imaging in sarcoidosis. Curr Opin Pulm Med 2002;8:457-463.
23. Miller DH, Kendall BE, Barter S, Johnson G, MacManus DG, Logsdail SJ, Ormerod IE, McDonald WI: Magnetic resonance imaging in central nervous system sarcoidosis. Neurology 1988;38:378-383.
24. Pickuth D, Spielmann RP, Heywang-Kobrunner SH: Role of radiology in the diagnosis of neurosarcoidosis. Eur Radiol 2000;10:941-944.
25. Allen RK, Sellars RE, Sandstrom PA: A prospective study of 32 patients with neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:118-125.
26. Pavese P, Brion JP, Chabre O, Fauconnier J, Pasquier B: Neurologic involvement in sarcoidosis. Federation of Systemic Diseases of Grenoble. Presse Méd 1999;28:168-172.